MedImmune
MedImmune, LLC is an American biotechnology company, which was acquired by AstraZeneca in 2007. The company's primary products are Synagis, FluMist, and Imfinzi, which are used for the prevention of Respiratory Syncytial Virus (RSV) and treatment of influenza and bladder cancer respectively.
History[edit | edit source]
MedImmune was founded in 1988 by Wayne Hockmeyer. It was initially a privately held company, but became publicly traded in 1991. In 2007, it was acquired by AstraZeneca for $15.6 billion.
Products[edit | edit source]
MedImmune has three primary products: Synagis, FluMist, and Imfinzi.
Synagis[edit | edit source]
Synagis is a monoclonal antibody used for the prevention of serious lower respiratory tract disease caused by RSV in pediatric patients.
FluMist[edit | edit source]
FluMist is a nasal spray influenza vaccine that protects against four strains of influenza.
Imfinzi[edit | edit source]
Imfinzi is a human monoclonal antibody that is designed to bind with PD-L1 and block the interaction of PD-L1 with PD-1 and CD80.
Research and Development[edit | edit source]
MedImmune conducts research in several areas of study, including oncology, respiratory, cardiovascular and metabolic disease, and infection and vaccines.
See Also[edit | edit source]
- AstraZeneca
- Biotechnology
- Monoclonal Antibodies
- Respiratory Syncytial Virus (RSV)
- Influenza
- Bladder Cancer
| MedImmune Resources | ||
|---|---|---|
|
| |
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD
